The ALINIA® $25 Co-Pay
Savings Program

Sign up online for the ALINIA $25 Co-pay Savings Program. Eligible patients can receive a maximum benefit up to $75, after an initial co-pay of $25.

Patients may sign up online and print out the savings coupon to present to their pharmacist.

Savings Card

Alinia $25 Co-Pay Savings Card terms and conditions apply:

  • Maximum benefit up to $75, after initial copay of $25, for Alinia┬« for Oral Suspension (NDC 27437-106-01)
  • Offer is valid for one (1) use
  • Patient is not eligible if prescriptions are paid in part or in full by any state or federally funded programs, including but not limited to Medicare or Medicaid, VA, DOD or Tri-Care and where prohibited by law
  • Coupon cannot be combined with any other free trial, coupon, discount, or prescription savings card
  • The selling, purchasing, trading or counterfeiting of this card is prohibited by law
  • Coupon cannot be copied
  • Lupin Pharmaceuticals, Inc. reserves the right to rescind, revoke, or amend this offer without notice
Copay Savings Program
The Bottom Line

Important Safety Information regarding Alinia®:

  • Do NOT take Alinia Tablets or Alinia for Oral Suspension if you are allergic to nitazoxanide or any other ingredient in the formulations.
  • Alinia Tablets or Alinia for Oral Suspension should be taken with food.
  • If you are a diabetic taking Alinia for Oral Suspension, please be aware that it contains 1.48 grams of sucrose for every 5 mL.
  • Alinia Tablets should NOT be taken by children 11 years or younger.
  • Please discuss with your doctor if you:
    • have hepatic, biliary, or renal disease.
    • are taking any other medications (for example, warfarin).
    • are a pregnant or a nursing woman.
    • are 65 years of age and older.
    • are HIV infected or have an immune disease (such as AIDS).
  • The most common side effects reported for Alinia Tablets during clinical trials were abdominal pain, diarrhea, headache and nausea, which were also reported by patients taking a placebo.
  • The most common side effects reported for Alinia for Oral Suspension during clinical trials were abdominal pain diarrhea, vomiting and headache, which were also reported by patients taking a placebo. These were typically mild and transient in nature. Of the 613 patients in pediatric trials, none discontinued therapy due to adverse events.

For more information, please read the Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit, or call 1-800-FDA-1088, or contact Romark at 1-813-282-8544.

Alinia® is a trademark of Romark, L.C.
Alinia® for Oral Suspension is distributed by Lupin Pharmaceuticals, Inc. under license from Romark, L.C.

Intended only for residents of the United States of America. ©2016 Romark, L.C., Tampa, Florida 33607-8416

The information contained in this website is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. Alinia® is not right for everyone. Decisions regarding healthcare must be made with a healthcare provider, considering the unique characteristics of the patient.

RM-AL-018-03V2 R03.16